AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
-3.65%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.36B
AUM Growth
-$619M
(-16%)
Cap. Flow
-$280M
Cap. Flow
% of AUM
-8.33%
Top 10 Holdings %
Top 10 Hldgs %
27.79%
Holding
302
New
82
Increased
54
Reduced
76
Closed
50
Top Buys
| 1 |
PTC Therapeutics
PTCT
|
$65.3M |
| 2 |
Immunovant
IMVT
|
$39.8M |
| 3 |
AB InBev
BUD
|
$38.9M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
$33.3M |
| 5 |
Charles River Laboratories
CRL
|
$30.6M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$114M |
| 2 |
Pfizer
PFE
|
$76.9M |
| 3 |
Johnson & Johnson
JNJ
|
$50.7M |
| 4 |
Neurocrine Biosciences
NBIX
|
$48.8M |
| 5 |
Incyte
INCY
|
$42.7M |
Sector Composition
| 1 | Healthcare | 66.93% |
| 2 | Consumer Staples | 12.81% |
| 3 | Technology | 8.13% |
| 4 | Consumer Discretionary | 7.55% |
| 5 | Communication Services | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Caesars Entertainment
CZR
$5.21B
| $723K | 0.01% |
+15,598
| New | +$723K |
|
152
Inspire Medical Systems
INSP
$2.57B
| $719K | 0.01% |
+3,623
| New | +$719K |
|
153
Ollie's Bargain Outlet
OLLI
$8.03B
| $673K | 0.01% |
+8,724
| New | +$673K |
|
154
Cadrenal Therapeutics
CVKD
$25.8M
| $668K | 0.01% |
+65,486
| New | +$668K |
|
155
Delcath Systems
DCTH
$378M
| $664K | 0.01% |
+164,000
| New | +$664K |
|
156
BJs Wholesale Club
BJ
$12.7B
| $636K | 0.01% |
+8,906
| New | +$636K |
|
157
Onconetix
ONCO
$4.41M
| $577K | 0.01% |
+332
| New | +$577K |
|
158
Dropbox
DBX
$7.89B
| $558K | 0.01% |
+20,501
| New | +$558K |
|
|
DRCTW
159
DELISTED
Direct Digital Holdings, Inc. Warrant
DRCTW
| $540K | 0.01% |
900,000
| – | – |
|
160
Cingulate
CING
$19.8M
| $535K | 0.01% |
+3,145
| New | +$535K |
|
|
APCXW
161
DELISTED
AppTech Payments Corp Warrant
APCXW
| $530K | 0.01% |
715,000
| – | – |
|
162
Ulta Beauty
ULTA
$23.7B
| $521K | 0.01% |
+1,304
| New | +$521K |
|
163
Flora Growth
FLGC
$12.7M
| $519K | 0.01% |
+11,478
| New | +$519K |
|
|
ELEV
164
DELISTED
Elevation Oncology
ELEV
| $497K | 0.01% |
750,000
-1,646,000
| -69% | -$1.09M |
|
165
Kontoor Brands
KTB
$4.41B
| $495K | 0.01% |
+11,266
| New | +$495K |
|
166
NeuroSense Therapeutics
NRSN
$26M
| $470K | 0.01% |
662,000
-604,000
| -48% | -$429K |
|
167
United Rentals
URI
$61.5B
| $455K | 0.01% |
+1,023
| New | +$455K |
|
168
Kroger
KR
$45.2B
| $446K | 0.01% |
+9,977
| New | +$446K |
|
169
Urban Outfitters
URBN
$6.25B
| $443K | 0.01% |
+13,543
| New | +$443K |
|
170
Aptevo Therapeutics
APVO
$5.19M
| $408K | 0.01% |
+38
| New | +$408K |
|
171
Capri Holdings
CPRI
$2.54B
| $392K | 0.01% |
7,443
-62,557
| -89% | -$3.29M |
|
|
RDHL
172
Redhill Biopharma
RDHL
$2.8M
| $369K | 0.01% |
+28,916
| New | +$369K |
|
173
Hilton Worldwide
HLT
$65.2B
| $356K | 0.01% |
2,371
-37,629
| -94% | -$5.65M |
|
|
ADTX
174
Aditxt
ADTX
$4.89M
| $350K | 0.01% |
+3
| New | +$350K |
|
175
Peraso
PRSO
$5.31M
| $317K | ﹤0.01% |
42,250
-17,775
| -30% | -$133K |
|